Literature DB >> 17923464

Comorbid conditions and outcomes after percutaneous coronary intervention.

M Singh1, C S Rihal, V L Roger, R J Lennon, J Spertus, A Jahangir, D R Holmes.   

Abstract

OBJECTIVE: To evaluate whether adding comorbid conditions to a risk model can help predict in-hospital outcome and long-term mortality after percutaneous coronary intervention (PCI).
DESIGN: Retrospective chart review
SETTING: Academic medical centre. PATIENTS: 7659 patients who had 9032 PCIs.
INTERVENTIONS: PCI performed at Mayo Clinic between 1 January 1999 and 30 June 2004. MAIN OUTCOME MEASURES: The Mayo Clinic Risk Score (MCRS) and the coronary artery disease (CAD)-specific index for determination of comorbid conditions in all patients.
RESULTS: The mean (SD) MCRS score was 6.5 (2.9). The CAD-specific index was 0 or 1 in 46%, 2 or 3 in 30% and 4 or higher in 24%. The rate of in-hospital major adverse cardiovascular events (MACE) increased with higher MCRS and CAD-specific index (Cochran-Armitage test, p<0.001 for both models). The c-statistic for the MCRS for in-hospital MACE was 0.78; adding the CAD-specific index did not improve its discriminatory ability for in-hospital MACE (c-statistic = 0.78; likelihood ratio test, p = 0.29). A total of 707 deaths after dismissal occurred after 7253 successful procedures. The c-statistic for all-cause mortality was 0.69 for the MCRS model alone and 0.75 for the MCRS and CAD-specific indices together (likelihood ratio test, p<0.001), indicating significant improvement in the discriminatory ability.
CONCLUSIONS: Addition of comorbid conditions to the MCRS adds significant prognostic information for post-dismissal mortality but adds little prognostic information about in-hospital complications after PCI. Such health-status measures should be included in future risk stratification models that predict long-term mortality after PCI.

Entities:  

Mesh:

Year:  2007        PMID: 17923464      PMCID: PMC2731585          DOI: 10.1136/hrt.2007.126649

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  23 in total

1.  Application of the New York State PTCA mortality model in patients undergoing stent implantation.

Authors:  D R Holmes; P B Berger; K N Garratt; V Mathew; M R Bell; G W Barsness; S T Higano; D E Grill; L N Hammes; C S Rihal
Journal:  Circulation       Date:  2000-08-01       Impact factor: 29.690

2.  Simplified risk score models accurately predict the risk of major in-hospital complications following percutaneous coronary intervention.

Authors:  F S Resnic; L Ohno-Machado; A Selwyn; D I Simon; J J Popma
Journal:  Am J Cardiol       Date:  2001-07-01       Impact factor: 2.778

3.  Predicting one-year mortality among elderly survivors of hospitalization for an acute myocardial infarction: results from the Cooperative Cardiovascular Project.

Authors:  H M Krumholz; J Chen; Y T Chen; Y Wang; M J Radford
Journal:  J Am Coll Cardiol       Date:  2001-08       Impact factor: 24.094

4.  Correlates of procedural complications and a simple integer risk score for percutaneous coronary intervention.

Authors:  Mandeep Singh; Ryan J Lennon; David R Holmes; Malcolm R Bell; Charanjit S Rihal
Journal:  J Am Coll Cardiol       Date:  2002-08-07       Impact factor: 24.094

5.  Prediction of death after percutaneous coronary interventional procedures.

Authors:  C S Rihal; D E Grill; M R Bell; P B Berger; K N Garratt; D R Holmes
Journal:  Am Heart J       Date:  2000-06       Impact factor: 4.749

6.  Frailty in older adults: evidence for a phenotype.

Authors:  L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-03       Impact factor: 6.053

7.  Simple bedside additive tool for prediction of in-hospital mortality after percutaneous coronary interventions.

Authors:  M Moscucci; E Kline-Rogers; D Share; M O'Donnell; A Maxwell-Eward; W L Meengs; P Kraft; A C DeFranco; J L Chambers; K Patel; J G McGinnity; K A Eagle
Journal:  Circulation       Date:  2001-07-17       Impact factor: 29.690

8.  TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy.

Authors:  D A Morrow; E M Antman; A Charlesworth; R Cairns; S A Murphy; J A de Lemos; R P Giugliano; C H McCabe; E Braunwald
Journal:  Circulation       Date:  2000-10-24       Impact factor: 29.690

9.  Development of a risk adjustment mortality model using the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR) experience: 1998-2000.

Authors:  Richard E Shaw; H Vernon Anderson; Ralph G Brindis; Ronald J Krone; Lloyd W Klein; Charles R McKay; Peter C Block; Leslee J Shaw; Kathleen Hewitt; William S Weintraub
Journal:  J Am Coll Cardiol       Date:  2002-04-03       Impact factor: 24.094

10.  Risk and predictors of stroke after myocardial infarction among the elderly: results from the Cooperative Cardiovascular Project.

Authors:  Judith H Lichtman; Harlan M Krumholz; Yun Wang; Martha J Radford; Lawrence M Brass
Journal:  Circulation       Date:  2002-03-05       Impact factor: 29.690

View more
  9 in total

1.  Comparison of frail patients versus nonfrail patients ≥65 years of age undergoing percutaneous coronary intervention.

Authors:  S Michael Gharacholou; Veronique L Roger; Ryan J Lennon; Charanjit S Rihal; Jeff A Sloan; John A Spertus; Mandeep Singh
Journal:  Am J Cardiol       Date:  2012-03-20       Impact factor: 2.778

2.  Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry.

Authors:  Eric D Peterson; David Dai; Elizabeth R DeLong; J Matthew Brennan; Mandeep Singh; Sunil V Rao; Richard E Shaw; Matthew T Roe; Kalon K L Ho; Lloyd W Klein; Ronald J Krone; William S Weintraub; Ralph G Brindis; John S Rumsfeld; John A Spertus
Journal:  J Am Coll Cardiol       Date:  2010-05-04       Impact factor: 24.094

3.  Influence of frailty and health status on outcomes in patients with coronary disease undergoing percutaneous revascularization.

Authors:  Mandeep Singh; Charanjit S Rihal; Ryan J Lennon; John A Spertus; K Sreekumaran Nair; Veronique L Roger
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2011-08-30

4.  Influence of comorbid conditions on one-year outcomes in non-ST-segment elevation acute coronary syndrome.

Authors:  Juan Sanchis; Julio Núñez; Vicente Bodí; Eduardo Núñez; Ana García-Alvarez; Clara Bonanad; Ander Regueiro; Xavier Bosch; Magda Heras; Joan Sala; Oscar Bielsa; Angel Llácer
Journal:  Mayo Clin Proc       Date:  2011-02-23       Impact factor: 7.616

Review 5.  Importance of frailty in patients with cardiovascular disease.

Authors:  Mandeep Singh; Ralph Stewart; Harvey White
Journal:  Eur Heart J       Date:  2014-05-26       Impact factor: 29.983

6.  Cardiac shock wave therapy reduces angina and improves myocardial function in patients with refractory coronary artery disease.

Authors:  Yu Wang; Tao Guo; Hong-Yan Cai; Tie-Kun Ma; Si-Ming Tao; Shuai Sun; Ming-Qing Chen; Yun Gu; Jia-Hua Pang; Jian-Ming Xiao; Xi-Yun Yang; Chao Yang
Journal:  Clin Cardiol       Date:  2010-11       Impact factor: 2.882

Review 7.  Is It Time to Begin a Public Campaign Concerning Frailty and Pre-frailty? A Review Article.

Authors:  Jerzy Sacha; Magdalena Sacha; Jacek Soboń; Zbigniew Borysiuk; Piotr Feusette
Journal:  Front Physiol       Date:  2017-07-11       Impact factor: 4.566

8.  The relationship of Charlson comorbidity index with stent restenosis and extent of coronary artery disease.

Authors:  Turgut Karabağ; Emіne Altuntaş; Belma Kalaycı; Bahar Şahіn; Mustafa Umut Somuncu; Mustafa Ozan Çakır
Journal:  Interv Med Appl Sci       Date:  2018-06

9.  Effect of Comorbidity On Unplanned Readmissions After Percutaneous Coronary Intervention (From The Nationwide Readmission Database).

Authors:  Chun Shing Kwok; Sara C Martinez; Samir Pancholy; Waqar Ahmed; Khaled Al-Shaibi; Jessica Potts; Mohamed Mohamed; Evangelos Kontopantelis; Nick Curzen; Mamas A Mamas
Journal:  Sci Rep       Date:  2018-07-24       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.